Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 495156, 10 pages
http://dx.doi.org/10.1155/2013/495156
Review Article

The Effect of Inflammatory Cytokines in Alcoholic Liver Disease

Third Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan

Received 1 September 2013; Accepted 12 November 2013

Academic Editor: Borna Relja

Copyright © 2013 Hideto Kawaratani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Browning and J. D. Horton, “Molecular mediators of hepatic steatosis and liver injury,” Journal of Clinical Investigation, vol. 114, no. 2, pp. 147–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. N. M. MacSween and A. D. Burt, “Histologic spectrum of alcoholic liver disease,” Seminars in Liver Disease, vol. 6, no. 3, pp. 221–232, 1986. View at Google Scholar · View at Scopus
  3. P. S. Haber, R. Warner, D. Seth, M. D. Gorrell, and G. W. McCaughan, “Pathogenesis and management of alcoholic hepatitis,” Journal of Gastroenterology and Hepatology, vol. 18, no. 12, pp. 1332–1344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Tsujimoto, S. Kuriyama, M. Yamazaki et al., “Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers,” International Journal of Oncology, vol. 18, no. 1, pp. 41–47, 2001. View at Google Scholar · View at Scopus
  5. T. Kitazawa, Y. Nakatani, M. Fujimoto, N. Tamura, M. Uemura, and H. Fukui, “The production of tumor necrosis factor-α by macrophages in rats with acute alcohol loading,” Alcoholism, vol. 27, no. 8, pp. 72S–75S, 2003. View at Google Scholar · View at Scopus
  6. Y. Iimuro, R. M. Gallucci, M. Luster, H. Kono, and R. G. Thurman, “Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat,” Hepatology, vol. 26, no. 6, pp. 1530–1537, 1997. View at Google Scholar · View at Scopus
  7. R. K. Rao, A. Seth, and P. Sheth, “Recent advances in alcoholic liver disease. I. Role of intestinal permeability and endotoxemia in alcoholic liver disease,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 286, no. 6, pp. G881–G884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. P.-H. Park, V. Thakur, M. T. Pritchard, M. R. McMullen, and L. E. Nagy, “Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin,” Journal of Gastroenterology and Hepatology, vol. 21, no. 3, pp. S30–S33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Canbay, A. E. Feldstein, H. Higuchi et al., “Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression,” Hepatology, vol. 38, no. 5, pp. 1188–1198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. J. McClain, Z. Song, S. S. Barve, D. B. Hill, and I. Deaciuc, “Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 287, no. 3, pp. G497–G502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Tilg and A. M. Diehl, “Cytokines in alcoholic and nonalcoholic steatohepatitis,” The New England Journal of Medicine, vol. 343, no. 20, pp. 1467–1467, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Gao, “Cytokines, STATs and liver disease,” Cellular & Molecular Immunology, vol. 2, no. 2, pp. 92–100, 2005. View at Google Scholar · View at Scopus
  13. F. Garcin, G. Lau You Hin, and J. Cote, “Aldehyde dehydrogenase in drosophila: developmental and functional aspects,” Alcohol, vol. 2, no. 1, pp. 85–89, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. C. S. Lieber and L. M. DeCarli, “The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 181, no. 2, pp. 279–287, 1972. View at Google Scholar · View at Scopus
  15. E. P. A. Neve and M. Ingelman-Sundberg, “Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane,” Journal of Biological Chemistry, vol. 275, no. 22, pp. 17130–17135, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Lieber, “Metabolic consequences of ethanol,” The Endocrinologist, vol. 4, no. 2, pp. 127–139, 1994. View at Google Scholar · View at Scopus
  17. M. Bilzer, F. Roggel, and A. L. Gerbes, “Role of Kupffer cells in host defense and liver disease,” Liver International, vol. 26, no. 10, pp. 1175–1186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Diehl, “Recent events in alcoholic liver disease: V. Effects of ethanol on liver regeneration,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 288, no. 1, pp. G1–G6, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Hansen, D. L. Cherwitz, and J. I. Allen, “The role of tumor necrosis factor-α in acute endotoxin-induced hepatotoxicity in ethanol-fed rats,” Hepatology, vol. 20, no. 2, pp. 461–474, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Aldred and L. E. Nagy, “Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF-α production in rat Kupffer cells,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 276, no. 1, pp. G98–G106, 1999. View at Google Scholar · View at Scopus
  21. D. B. Hill, L. Marsano, D. Cohen, J. Allen, S. Shedlofsky, and C. J. McClain, “Increased plasma interleukin-6 concentrations in alcoholic hepatitis,” The Journal of Laboratory and Clinical Medicine, vol. 119, no. 5, pp. 547–552, 1992. View at Google Scholar · View at Scopus
  22. H. Kawaratani, T. Tsujimoto, T. Kitazawa et al., “Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet,” World Journal of Gastroenterology, vol. 14, no. 43, pp. 6655–6661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Crespo, A. Cayoen, P. Fernendez-Gil et al., “Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients,” Hepatology, vol. 34, no. 6, pp. 1158–1163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Matsuyama, M. Uemura, M. Ishikawa et al., “Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis,” Alcoholism, vol. 31, no. 1, pp. S27–S35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ishikawa, M. Uemura, T. Matsuyama et al., “Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia,” Alcoholism, vol. 34, no. 1, pp. S25–S33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Uemura, Y. Fujimura, T. Matsuyama et al., “Potential role of ADAMTS13 in the progression of alcoholic hepatitis,” Current Drug Abuse Reviews, vol. 1, no. 2, pp. 188–196, 2008. View at Google Scholar · View at Scopus
  27. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil, “Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial,” Gastroenterology, vol. 119, no. 6, pp. 1637–1648, 2000. View at Google Scholar · View at Scopus
  28. H. Tilg, R. Jalan, A. Kaser et al., “Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis,” Journal of Hepatology, vol. 38, no. 4, pp. 419–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kawaratani, T. Tsujimoto, T. Kitazawa, H. Yoshiji, M. Uemura, and H. Fukui, “Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model,” Journal of Gastroenterology and Hepatology, vol. 26, no. 4, pp. 775–783, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Sheron, G. Bird, J. Goka, G. Alexander, and R. Williams, “Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis,” Clinical and Experimental Immunology, vol. 84, no. 3, pp. 449–453, 1991. View at Google Scholar · View at Scopus
  31. F. Hong, W.-H. Kim, Z. Tian et al., “Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins,” Oncogene, vol. 21, no. 1, pp. 32–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Latvala, J. Hietala, H. Koivisto, K. Järvi, P. Anttila, and O. Niemelä, “Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease,” American Journal of Gastroenterology, vol. 100, no. 6, pp. 1303–1310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. O. El-Assal, F. Hong, W.-H. Kim, S. Radaeva, and B. Gao, “IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver,” Cellular & molecular immunology, vol. 1, no. 3, pp. 205–211, 2004. View at Google Scholar · View at Scopus
  34. X. Zhang, S. Tachibana, H. Wang et al., “Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice,” Hepatology, vol. 52, no. 6, pp. 2137–2147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Rabe, A. Chalaris, U. May et al., “Transgenic blockade of interleukin 6 transsignaling abrogates inflammation,” Blood, vol. 111, no. 3, pp. 1021–1028, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Mathurin, Q.-G. Deng, A. Keshavarzian, S. Choudhary, E. W. Holmes, and H. Tsukamoto, “Exacerbation of alcoholic liver injury by enteral endotoxin in rats,” Hepatology, vol. 32, no. 5, pp. 1008–1017, 2000. View at Google Scholar · View at Scopus
  37. C. M. Hawrylowicz and A. O'Garra, “Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma,” Nature Reviews Immunology, vol. 5, no. 4, pp. 271–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Louis, O. Le Moine, M. Goldman, and J. Devière, “Modulation of liver injury by interleukin-10,” Acta Gastro-Enterologica Belgica, vol. 66, no. 1, pp. 7–14, 2003. View at Google Scholar · View at Scopus
  39. D. F. Fiorentino, A. Zlotnik, P. Vieira et al., “IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells,” Journal of Immunology, vol. 146, no. 10, pp. 3444–3451, 1991. View at Google Scholar · View at Scopus
  40. R. De Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, and J. E. De Vries, “Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes,” Journal of Experimental Medicine, vol. 174, no. 5, pp. 1209–1220, 1991. View at Google Scholar · View at Scopus
  41. D. B. Hill, N. B. D'Souza, E. Y. Lee, R. Burikhanov, I. V. Deaciuc, and W. J. S. De Villiers, “A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide,” Alcoholism, vol. 26, no. 1, pp. 74–82, 2002. View at Google Scholar · View at Scopus
  42. A. M. Miller, H. Wang, A. Bertola et al., “Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice,” Hepatology, vol. 54, no. 3, pp. 846–856, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. A. A. Nanji, K. Jokelainen, A. Rahemtulla et al., “Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat,” Hepatology, vol. 30, no. 4, pp. 934–943, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Jura, P. Wegrzyn, M. Korostyński et al., “Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays,” Biochimica et Biophysica Acta, vol. 1779, no. 6-7, pp. 383–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. E. V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto, “Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells,” Nature Immunology, vol. 8, no. 9, pp. 942–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. C. T. Weaver, R. D. Hatton, P. R. Mangan, and L. E. Harrington, “IL-17 family cytokines and the expanding diversity of effector T cell lineages,” Annual Review of Immunology, vol. 25, pp. 821–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Lafdil, A. M. Miller, S. H. Ki, and B. Gao, “Th17 cells and their associated cytokines in liver diseases,” Cellular and Molecular Immunology, vol. 7, no. 4, pp. 250–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Lemmers, C. Moreno, T. Gustot et al., “The interleukin-17 pathway is involved in human alcoholic liver disease,” Hepatology, vol. 49, no. 2, pp. 646–657, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Nanji, S. Zhao, S. M. H. Sadrzadeh, A. J. Dannenberg, S. R. Tahan, and D. J. Waxman, “Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats,” Alcoholism, vol. 18, no. 5, pp. 1280–1285, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. S. H. Ki, O. Park, M. Zheng et al., “Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3,” Hepatology, vol. 52, no. 4, pp. 1291–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. C. A. Dinarello, “Interleukin-1β and the autoinflammatory diseases,” The New England Journal of Medicine, vol. 360, no. 23, pp. 2467–2470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Petrasek, S. Bala, T. Csak et al., “IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice,” The Journal of Clinical Investigation, vol. 122, pp. 3476–3489, 2012. View at Google Scholar
  53. H. Tilg, A. Wilmer, W. Vogel et al., “Serum levels of cytokines in chronic liver diseases,” Gastroenterology, vol. 103, no. 1, pp. 264–274, 1992. View at Google Scholar · View at Scopus
  54. M. Mertens and J. A. Singh, “Anakinra for rheumatoid arthritis,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD005121, 2009. View at Google Scholar · View at Scopus
  55. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Gustot, A. Lemmers, C. Moreno et al., “Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver,” Hepatology, vol. 43, no. 5, pp. 989–1000, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Hritz, P. Mandrekar, A. Velayudham et al., “The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88,” Hepatology, vol. 48, no. 4, pp. 1224–1231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Seki and D. A. Brenner, “Toll-like receptors and adaptor molecules in liver disease: update,” Hepatology, vol. 48, no. 1, pp. 322–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Isogawa, M. D. Robek, Y. Furuichi, and F. V. Chisari, “Toll-like receptor signaling inhibits hepatitis B virus replication in vivo,” Journal of Virology, vol. 79, no. 11, pp. 7269–7272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr., “A human homologue of the Drosophila toll protein signals activation of adaptive immunity,” Nature, vol. 388, no. 6640, pp. 394–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Yamamoto, S. Sato, H. Hemmi et al., “Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway,” Science, vol. 301, no. 5633, pp. 640–643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Szabo, J. Petrasek, and S. Bala, “Innate immunity and alcoholic liver disease,” Digestive Diseases, vol. 30, pp. S55–S60, 2012. View at Google Scholar
  63. G. Szabo, P. Mandrekar, J. Petrasek, and D. Catalano, “The unfolding web of innate immune dysregulation in alcoholic liver injury,” Alcoholism, vol. 35, no. 5, pp. 782–786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Yin, B. U. Bradford, M. D. Wheeler et al., “Reduced early alcohol-induced liver injury in CD14-deficient mice,” Journal of Immunology, vol. 166, no. 7, pp. 4737–4742, 2001. View at Google Scholar · View at Scopus
  65. Y.-H. Paik, R. F. Schwabe, R. Bataller, M. P. Russo, C. Jobin, and D. A. Brenner, “Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells,” Hepatology, vol. 37, no. 5, pp. 1043–1055, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. L. E. Nagy, “Recent insights into the role of the innate immune system in the development of alcoholic liver disease,” Experimental Biology and Medicine, vol. 228, no. 8, pp. 882–890, 2003. View at Google Scholar · View at Scopus
  67. M. Fujimoto, M. Uemura, Y. Nakatani et al., “Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance,” Alcoholism, vol. 24, no. 4, pp. S48–S54, 2000. View at Google Scholar · View at Scopus
  68. H. Fukui, B. Brauner, J. C. Bode, and C. Bode, “Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay,” Journal of Hepatology, vol. 12, no. 2, pp. 162–169, 1991. View at Google Scholar · View at Scopus
  69. T. Gustot, A. Lemmers, C. Moreno et al., “Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver,” Hepatology, vol. 43, no. 5, pp. 989–1000, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Mandrekar, D. Catalano, B. White, and G. Szabo, “Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10,” Alcoholism, vol. 30, no. 1, pp. 135–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. J. S. Byun, Y. G. Suh, H. S. Yi et al., “Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice,” Journal of Hepatology, vol. 58, pp. 342–349, 2013. View at Google Scholar
  72. M. Samanta, D. Iwakiri, and K. Takada, “Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling,” Oncogene, vol. 27, no. 30, pp. 4150–4160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. E. Meylan and J. Tschopp, “Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses,” Molecular Cell, vol. 22, no. 5, pp. 561–569, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. X.-J. Zhao, Q. Dong, J. Bindas et al., “TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol,” Journal of Immunology, vol. 181, no. 5, pp. 3049–3056, 2008. View at Google Scholar · View at Scopus
  75. M. Dominguez, R. Miquel, J. Colmenero et al., “Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis,” Gastroenterology, vol. 136, no. 5, pp. 1639–1650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Colmenero, R. Bataller, P. Sancho-Bru et al., “Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity,” Gastroenterology, vol. 132, no. 2, pp. 687–697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. K. J. Simpson, N. C. Henderson, C. L. Bone-Larson, N. W. Lukacs, C. M. Hogaboam, and S. L. Kunkel, “Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles,” Clinical Science, vol. 104, no. 1, pp. 47–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Jiang, D. I. Beller, G. Frendl, and D. T. Graves, “Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes,” Journal of Immunology, vol. 148, no. 8, pp. 2423–2428, 1992. View at Google Scholar · View at Scopus
  79. N. C. Fisher, D. A. H. Neil, A. Williams, and D. H. Adams, “Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 α in alcoholic liver disease,” Gut, vol. 45, no. 3, pp. 416–420, 1999. View at Google Scholar · View at Scopus
  80. B. Lu, B. J. Rutledge, L. Gu et al., “Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice,” The Journal of Experimental Medicine, vol. 187, no. 4, pp. 601–608, 1998. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Mandrekar, A. Ambade, A. Lim, G. Szabo, and D. Catalano, “An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice,” Hepatology, vol. 54, no. 6, pp. 2185–2197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Schroder and J. Tschopp, “The inflammasomes,” Cell, vol. 140, no. 6, pp. 821–832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Cayrol and J.-P. Girard, “The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 22, pp. 9021–9026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology, vol. 27, pp. 229–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. S. L. Valles, A. M. Blanco, I. Azorin et al., “Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes,” Alcoholism, vol. 27, no. 12, pp. 1979–1986, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Lech, A. Avila-Ferrufino, V. Skuginna, H. E. Susanti, and H.-J. Anders, “Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice,” International Immunology, vol. 22, no. 9, pp. 717–728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Iimuro, B. U. Bradford, S. Yamashina et al., “The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat,” Hepatology, vol. 31, no. 2, pp. 391–398, 2000. View at Google Scholar · View at Scopus
  88. D. Wu and A. I. Cederbaum, “Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1,” Alcoholism, vol. 23, no. 1, pp. 67–76, 1999. View at Google Scholar · View at Scopus
  89. M. D. Wheeler, “Endotoxin and kupffer cell activation in alcoholic liver disease,” Alcohol Research and Health, vol. 27, no. 4, pp. 300–306, 2003. View at Google Scholar · View at Scopus
  90. E. Albano, “Oxidative mechanisms in the pathogenesis of alcoholic liver disease,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 9–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Keshavarzian, A. Farhadi, C. B. Forsyth et al., “Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats,” Journal of Hepatology, vol. 50, no. 3, pp. 538–547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Keshavarzian, E. W. Holmes, M. Patel, F. Iber, J. Z. Fields, and S. Pethkar, “Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol- induced liver damage,” American Journal of Gastroenterology, vol. 94, no. 1, pp. 200–207, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Bala, M. Marcos, K. Kodys et al., “Up-regulation of microRNA-155 in macrophages contributes to increased Tumor Necrosis Factor α (TNFα) production via increased mRNA half-life in alcoholic liver disease,” Journal of Biological Chemistry, vol. 286, no. 2, pp. 1436–1444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Sheth, A. Seth, K. J. Atkinson et al., “Acetaldehyde dissociates the PTP1B-E-cadherin-β-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism,” The Biochemical Journal, vol. 402, no. 2, pp. 291–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. Z. Yumuk, S. Ozdemirci, B. Faruk Erden, and V. Dundar, “The effect of long-term ethanol feeding on Brucella melitensis infection of rats,” Alcohol and Alcoholism, vol. 36, no. 4, pp. 314–317, 2001. View at Google Scholar · View at Scopus
  96. M. J. Kavanaugh, C. Clark, M. Goto et al., “Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function,” Burns, vol. 31, no. 3, pp. 290–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. D. Wheeler, H. Kono, M. Yin et al., “The role of kupffer cell oxidant production in early ethanol-induced liver disease,” Free Radical Biology and Medicine, vol. 31, no. 12, pp. 1544–1549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. V. Thakur, M. R. McMullen, M. T. Pritchard, and L. E. Nagy, “Regulation of macrophage activation in alcoholic liver disease,” Journal of Gastroenterology and Hepatology, vol. 22, no. 1, pp. S53–S56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. R. Rao, “Endotoxemia and gut barrier dysfunction in alcoholic liver disease,” Hepatology, vol. 50, no. 2, pp. 638–644, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. A. W. Yan, D. E. Fouts, J. Brandl et al., “Enteric dysbiosis associated with a mouse model of alcoholic liver disease,” Hepatology, vol. 53, no. 1, pp. 96–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Keshavarzian, J. Z. Fields, J. Vaeth, and E. W. Holmes, “The differing effects of acute and chronic alcohol on gastric and intestinal permeability,” American Journal of Gastroenterology, vol. 89, no. 12, pp. 2205–2211, 1994. View at Google Scholar · View at Scopus
  102. M. A. Choudhry, N. Fazal, M. Goto, R. L. Gamelli, and M. M. Sayeed, “Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 282, no. 6, pp. G937–G947, 2002. View at Google Scholar · View at Scopus
  103. A. Keshavarzian, S. Choudhary, E. W. Holmes et al., “Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 2, pp. 442–448, 2001. View at Google Scholar · View at Scopus
  104. G. Szabo and S. Bala, “Alcoholic liver disease and the gut-liver axis,” World Journal of Gastroenterology, vol. 16, no. 11, pp. 1321–1329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. Adachi, L. E. Moore, B. U. Bradford, W. Gao, and R. G. Thurman, “Antibiotics prevent liver injury in rats following long-term exposure to ethanol,” Gastroenterology, vol. 108, no. 1, pp. 218–224, 1995. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Gao and R. Bataller, “Alcoholic liver disease: pathogenesis and new therapeutic targets,” Gastroenterology, vol. 141, no. 5, pp. 1572–1585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. R. S. O'Shea, S. Dasarathy, and A. J. McCullough, “Alcoholic liver disease,” Hepatology, vol. 51, pp. 307–328, 2010. View at Google Scholar
  108. C. S. Lieber and L. M. DeCarli, “Alcoholic liver injury: experimental models in rats and baboons,” Advances in Experimental Medicine and Biology, vol. 59, pp. 379–393, 1975. View at Google Scholar · View at Scopus
  109. H. Tsukamoto, S. W. French, and N. Benson, “Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet,” Hepatology, vol. 5, no. 2, pp. 224–232, 1985. View at Google Scholar · View at Scopus
  110. H. Tsukamoto, S. J. Towner, L. M. Ciofalo, and S. W. French, “Ethanol-induced liver fibrosis in rats fed high fat diet,” Hepatology, vol. 6, no. 5, pp. 814–822, 1986. View at Google Scholar · View at Scopus
  111. S. W. French, “Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease,” Journal of Biomedical Science, vol. 8, no. 1, pp. 20–27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  112. A. A. Nanji, U. Khettry, and S. M. H. Sadrzadeh, “Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease),” Proceedings of the Society for Experimental Biology and Medicine, vol. 205, no. 3, pp. 243–247, 1994. View at Google Scholar · View at Scopus
  113. T. Tsujimoto, H. Kawaratani, H. Yoshiji, M. Uemura, and H. Fukui, “Recent developments in the treatment of alcoholic chronic pancreatitis,” Current Drug Abuse Reviews, vol. 1, no. 2, pp. 197–202, 2008. View at Google Scholar · View at Scopus